1. Home
  2. LQDA vs ATMU Comparison

LQDA vs ATMU Comparison

Compare LQDA & ATMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

SELL

Current Price

$34.32

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo Atmus Filtration Technologies Inc.

ATMU

Atmus Filtration Technologies Inc.

SELL

Current Price

$44.14

Market Cap

4.4B

ML Signal

SELL

Company Overview

Basic Information
Metric
LQDA
ATMU
Founded
2004
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.4B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
LQDA
ATMU
Price
$34.32
$44.14
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$54.38
★ $62.60
AVG Volume (30 Days)
★ 4.6M
591.9K
Earning Date
11-02-2026
11-06-2026
Dividend Yield
N/A
★ 0.54%
EPS Growth
★ 51.81
12.61
EPS
1.26
★ 1.37
Revenue
$158,320,000.00
★ $1,764,300,000.00
Revenue This Year
$357.27
$14.05
Revenue Next Year
$1.34
$5.07
P/E Ratio
★ $27.38
$32.34
Revenue Growth
★ 1031.18
5.67
52 Week Low
$21.97
$40.75
52 Week High
$93.61
$66.50

Technical Indicators

Market Signals
Indicator
LQDA
ATMU
Relative Strength Index (RSI) 34.77 46.23
Support Level $32.63 $43.76
Resistance Level $42.62 $45.68
Average True Range (ATR) 2.90 1.33
MACD 0.11 0.12
Stochastic Oscillator 23.72 53.50

Price Performance

Historical Comparison
LQDA
ATMU

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About ATMU Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.

Share on Social Networks: